<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30939" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Vaginal Candidiasis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jeanmonod</surname>
            <given-names>Rebecca</given-names>
          </name>
          <aff>St. Luke's University Health Network</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chippa</surname>
            <given-names>Venu</given-names>
          </name>
          <aff>Indiana university</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jeanmonod</surname>
            <given-names>Donald</given-names>
          </name>
          <aff>St. Luke's University Health Network</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rebecca Jeanmonod declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Venu Chippa declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Donald Jeanmonod declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30939.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Vulvovaginitis, or inflammation of the vulva and vagina, most commonly occurs in reproductive-aged women and is caused by several underlying etiologies. Candidiasis is a fungal infection caused by <italic toggle="yes">Candida albicans</italic>, a polymorphic opportunistic fungus; vulvovaginitis secondary to candidiasis is also known as vaginal candidiasis.&#x000a0;Candidal vulvovaginitis is responsible for about one-third of vulvovaginitis occurrences. Typical clinical features include&#x000a0;vulvar and vaginal erythema, excoriations, thick white adherent discharge, and swelling. The condition is primarily diagnosed by clinical examination and diagnostic studies, including&#x000a0;vaginal wet prep, pH testing, and cultures to exclude other etiologies of vaginal discharge and infection (eg, bacterial vaginosis and gonococcal and chlamydial disease).&#x000a0;This activity for healthcare professionals is designed to enhance the learner's competence when managing vaginal candidiasis, equipping them with updated knowledge, skills, and strategies for timely identification, effective interventions, and improved coordination of care, leading to better outcomes for patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify clinical manifestations and risk factors associated with vaginal candidiasis for accurate diagnosis.</p></list-item><list-item><p>Differentiate vaginal candidiasis from other vaginal infections through thorough clinical assessment and diagnostic evaluation.</p></list-item><list-item><p>Implement evidence-based treatment strategies promptly, considering antifungal agents and lifestyle modifications.</p></list-item><list-item><p>Communicate the diagnosis, treatment plan, and preventive measures effectively with patients and among team members.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30939&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30939">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30939.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Vulvovaginitis, or inflammation of the vulva and vagina, most commonly occurs in reproductive-aged women and is caused by several underlying etiologies. Candidiasis is a fungal infection caused by&#x000a0;<italic toggle="yes">Candida albicans</italic>, a polymorphic opportunistic fungus; vulvovaginitis secondary to candidiasis is also known as vaginal candidiasis.&#x000a0;Candidal vulvovaginitis is responsible for about one-third of vulvovaginitis occurrences.<xref ref-type="bibr" rid="article-30939.r1">[1]</xref> Typical clinical features include&#x000a0;vulvar and vaginal erythema, excoriations, thick white adherent discharge, and swelling. The condition is primarily diagnosed by clinical examination and diagnostic studies, including&#x000a0;vaginal wet prep, pH testing, and cultures to exclude other etiologies of vaginal discharge and infection (eg, bacterial vaginosis and gonococcal and chlamydial disease).&#x000a0;This activity for healthcare professionals is designed to enhance the learner's competence when managing vaginal candidiasis, equipping them with updated knowledge, skills, and strategies for timely identification, effective interventions, and improved coordination of care, leading to better outcomes for patients.</p>
      </sec>
      <sec id="article-30939.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Candidal vulvovaginitis is caused by inflammatory changes in the vaginal and vulvar epithelium secondary to infection with <italic toggle="yes">Candida</italic> species, most commonly <italic toggle="yes">Candida albicans</italic>. However,&#x000a0;<italic toggle="yes">Candida</italic> is part of the normal flora in many women, identified in&#x000a0;10% of asymptomatic women.<xref ref-type="bibr" rid="article-30939.r2">[2]</xref> Therefore, candidal vulvovaginitis requires both the presence of <italic toggle="yes">Candida</italic>&#x000a0;in the vagina and associated symptoms (eg, irritation, itching, dysuria, or inflammation).<xref ref-type="bibr" rid="article-30939.r3">[3]</xref></p>
      </sec>
      <sec id="article-30939.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Candidal vulvovaginitis is a common condition responsible for a third of all cases of vulvovaginitis in reproductive-aged women. Approximately 70% of women report having had candidal vulvovaginitis in their lifetime, and an estimated 8% of women suffer recurrent candidal vulvovaginitis.<xref ref-type="bibr" rid="article-30939.r4">[4]</xref> The most common responsible pathogen is <italic toggle="yes">C. albicans, </italic>accounting for&#x000a0;90% of cases, with most of the remaining cases caused by <italic toggle="yes">Candida glabrata</italic>. Because over-the-counter treatments are widely available, candidal vulvovaginitis is under-reported; therefore, detailed epidemiological data for this disease process is unavailable.<xref ref-type="bibr" rid="article-30939.r5">[5]</xref>&#x000a0;Furthermore, diagnosis is based on both clinical and ancillary evaluation. As a result, epidemiologic reports based on culture alone, in which 10% of asymptomatic women have positive candidal cultures, overestimate the disease incidence. Furthermore, studies demonstrate that because self-diagnosis is inaccurate, data derived from a patient query is also imprecise.<xref ref-type="bibr" rid="article-30939.r6">[6]</xref></p>
        <p>Recognized risk factors for acute candidal vulvovaginitis include estrogen use, elevated endogenous estrogens (eg, pregnancy or obesity), diabetes mellitus, immunosuppression (ie, chemotherapy or antimetabolite medications, HIV infection, or transplant patients), and broad-spectrum antibiotic use. Although candidal vulvovaginitis is more common in sexually active women, evidence that candidal infection is sexually transmitted is lacking. Patients with recurrent candidal vulvovaginitis, defined as 4 or more episodes of culture-proven candidal vulvovaginitis, have predisposing genetic factors that cause them to be susceptible to recurrent fungal infections. These factors may also cause a predisposition to <italic toggle="yes">Candida</italic>&#x000a0;hypersensitivity reactions.<xref ref-type="bibr" rid="article-30939.r7">[7]</xref></p>
      </sec>
      <sec id="article-30939.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Candidal vulvovaginitis occurs when <italic toggle="yes">Candida</italic> species superficially penetrate the mucosal lining of the vagina and cause an inflammatory response. The dominant inflammatory cells are typically polymorphonuclear cells and macrophages. The inflammatory response results in copious thick discharge and vaginal irritation, excoriations, dysuria, itching, burning, dyspareunia, or swelling.<xref ref-type="bibr" rid="article-30939.r8">[8]</xref></p>
      </sec>
      <sec id="article-30939.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Characteristic clinical symptoms of vaginal candidiasis include vaginal and vulvar irritation, itching, and burning. Symptoms are often prominent just before the patient's menstrual period. Many patients have a history of similar symptoms and report attempting over-the-counter treatment with topical agents or alternative therapies.</p>
        <p>On pelvic exam, common findings include vulvar and vaginal erythema, excoriations, thick white adherent discharge, and swelling. In some patients, little to no discharge is noted. In patients with candidal vulvovaginitis, inflammation is evident during a pelvic exam. However, the cervix is typically normal and not inflamed. The patient should not have cervical motion tenderness, and there should be no abnormal discharge from the cervical os. Ulcers, asymmetric swelling or masses, or foreign bodies should prompt consideration of differential diagnoses. The degree of irritation is typically severe in patients with acute vulvovaginal candidiasis. Conversely, patients with <italic toggle="yes">Candida glabrata </italic>infections&#x000a0;usually have mild symptoms. Various vulvovaginitis etiologies have similar presentations, and therefore, further diagnostic studies, including wet mount, whiff testing, and pH testing, should be considered for uncertain diagnoses.<xref ref-type="bibr" rid="article-30939.r9">[9]</xref></p>
      </sec>
      <sec id="article-30939.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnostic studies utilized to confirm the presence of&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;include 10% potassium hydroxide (KOH) and wet mount smears of the vaginal discharge&#x000a0;for microscopy, pH testing, and potentially&#x000a0;fungal culture or commercial polymerase chain reaction (PCR) tests.&#x000a0;In patients with vulvovaginal candidiasis, the vaginal pH is typically&#x000a0;below&#x000a0;5.[ACOG Practice bulletin 215 Vaginitis in Nonpregnant] Characteristic findings of vaginal candidiasis include the prominence of lactobacillus bacteria and inflammatory cells on wet prep, a negative Whiff test (ie, no fishy odor with the application of KOH to the slide), and budding yeast, hyphae, or pseudohyphae on microscopy, which are typically seen most easily on the KOH prep.<xref ref-type="bibr" rid="article-30939.r10">[10]</xref>&#x000a0;Microscopy and pH testing can also identify clue cells, indicating bacterial vaginosis, and trichomonads, indicating trichomoniasis, which should be ruled out (or diagnosed) concurrently.<xref ref-type="bibr" rid="article-30939.r11">[11]</xref></p>
        <p>Most infections are secondary to&#x000a0;<italic toggle="yes">Candida albicans;&#x000a0;</italic>therefore<italic toggle="yes">,</italic>&#x000a0;consistent microscopy findings in the clinical setting of a reproductive-age woman with vulvovaginitis, confirmatory cultures for&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;are unnecessary. Cultures should be considered in patients with recurrent disease and patients with a negative work-up in the setting of symptoms consistent with vulvovaginal candidiasis.<xref ref-type="bibr" rid="article-30939.r12">[12]</xref>&#x000a0;(Ref: ACOG PB 215).&#x000a0;However, if&#x000a0;cultures cannot be performed, empiric treatment is reasonable.<xref ref-type="bibr" rid="article-30939.r13">[13]</xref>&#x000a0;</p>
        <p>Because&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;species are part of normal vaginal flora in many women, routine cultures in asymptomatic women are discouraged.&#x000a0;</p>
      </sec>
      <sec id="article-30939.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Acute candidal vulvovaginitis is treated with antifungal agents. Since most candidal vulvovaginitis cases are secondary to <italic toggle="yes">C albicans </italic>species, and&#x000a0;<italic toggle="yes">C albicans</italic> does not&#x000a0;demonstrate resistance to azole antifungals, these are the agents of choice.<xref ref-type="bibr" rid="article-30939.r14">[14]</xref> Antifungals may be administered through several methods, including a single dose of fluconazole 150 mg orally or terconazole applied intravaginally once or in multiple dose regimens ranging from 3 to 7 days available over the counter. These options are equally efficacious in patients with uncomplicated disease (eg, immunocompetent status or nonrecurrent candidal vulvovaginitis). Therefore, treatment decisions may be based on cost, patient preference, and drug interactions. In unresponsive patients, cultures may be warranted to look for other <italic toggle="yes">Candida</italic> species, often resistant to standard therapy.<xref ref-type="bibr" rid="article-30939.r15">[15]</xref></p>
        <p>For complicated candidal vulvovaginitis, including patients who are immunosuppressed or have a recurrent infection, extended treatment regimens are commonly utilized, such as intravaginal azole therapy for at least 1 week or oral treatment with fluconazole 150 mg (renally adjusted for CrCl &#x0003c;50 ml/min) once every 3 days for 3 doses. Patients with recurrent candidal vulvovaginitis may benefit from suppressive therapy with weekly oral fluconazole for 6 months. However, pregnant patients should not be given oral antifungals. In these patients, a 7-day course of intravaginal treatment is recommended. Fluconazole is considered safe in breastfeeding women.<xref ref-type="bibr" rid="article-30939.r16">[16]</xref>&#x000a0;Nonpharmacologic therapies (eg, intravaginal or oral yogurt therapy, intravaginal garlic, or douching) have not been found to be effective.</p>
      </sec>
      <sec id="article-30939.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses that should also be considered include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Allergic reaction</p>
          </list-item>
          <list-item>
            <p>Atopic dermatitis</p>
          </list-item>
          <list-item>
            <p>Lichen sclerosis</p>
          </list-item>
          <list-item>
            <p>Lichen simplex chronicus</p>
          </list-item>
          <list-item>
            <p>Neoplasm</p>
          </list-item>
          <list-item>
            <p>Paget disease</p>
          </list-item>
          <list-item>
            <p>Physiologic leukorrhea</p>
          </list-item>
          <list-item>
            <p>Psoriasis</p>
          </list-item>
          <list-item>
            <p>Sexual abuse</p>
          </list-item>
          <list-item>
            <p>Vulvodynia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30939.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Despite appropriate treatment, recurrence is relatively common and is estimated to range from 14% to 28% in otherwise healthy individuals.<xref ref-type="bibr" rid="article-30939.r17">[17]</xref> Most often, recurrent disease arises from persistent vaginal organisms or endogenous reinfection with an identical strain of&#x000a0;<italic toggle="yes">Candida</italic>. Less commonly, the disease may result from a new strain of&#x000a0;<italic toggle="yes">Candida</italic>. Recurrent disease may be triggered by antibiotic use, sexual activity, or dietary factors. Genetic susceptibility may also affect a person's risk for recurrent disease.</p>
        <p>Topical imidazole and oral fluconazole are less likely to be effective in patients with non-<italic toggle="yes">albicans</italic> species of&#x000a0;<italic toggle="yes">Candida</italic>. Therefore, fungal culture is indicated in patients with persistent symptoms after standard treatment for uncomplicated vulvovaginal candidiasis. Boric acid (600 mg vaginally for at least 14 days) is often effective against&#x000a0;<italic toggle="yes">C glabrata</italic> and other atypical species. Note that boric acid can be fatal if orally ingested, so patients must be well-counseled on its use.<xref ref-type="bibr" rid="article-30939.r18">[18]</xref></p>
      </sec>
      <sec id="article-30939.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications secondary to vaginal candidiasis are rare but, in severe cases, may cause extensive vulvar erythema, edema, excoriation, and vaginal or vulvar fissures.<xref ref-type="bibr" rid="article-30939.r13">[13]</xref>&#x000a0;Adverse events that may occur with antifungal treatment include abdominal pain, nausea and vomiting, diarrhea, flatulence, headache, central nervous system disorder, musculoskeletal disorder, rash, allergic reaction, menstrual disorder, and alopecia.<xref ref-type="bibr" rid="article-30939.r19">[19]</xref></p>
      </sec>
      <sec id="article-30939.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be instructed only to use recommended vaginal candidiasis treatments as inappropriate use of over-the-counter preparations can result in treatment delay and the development of other vulvovaginitis etiologies. Clinicians should also counsel patients that there is little evidence supporting the use of probiotics or homeopathic medications for vaginal candidiasis treatment. Individuals with persistent symptoms&#x000a0;should be instructed to return for follow-up visits.<xref ref-type="bibr" rid="article-30939.r13">[13]</xref>&#x000a0;General recommendations to help prevent recurrent episodes of <italic toggle="yes">Candida</italic> infection include keeping the vaginal area dry by changing out of wet clothes immediately after swimming or exercising, avoiding soap in the vulvovaginal area, wearing breathable fabrics, avoiding douches, and considering preventative antifungal treatment&#x000a0;while taking antibiotics.</p>
      </sec>
      <sec id="article-30939.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Although vaginitis is not a dangerous disease, symptoms are often irritating and, in severe cases, disabling. Therefore, clinicians should address social issues and sexual dysfunction in addition to the infection itself.&#x000a0;A broad differential diagnosis should always be considered. Trauma, abuse, foreign body, malignancy, immune diseases, inflammatory bowel disease, and sexually transmitted infections can all present with vaginal discomfort. Clinicians should always perform a careful and complete physical exam, appropriate ancillary testing, and further diagnostic studies if treatment failure occurs.</p>
      </sec>
      <sec id="article-30939.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Candida vulvovaginitis is usually managed by a gynecologist, nurse practitioner, primary care clinician, or internist. The condition has been clinically diagnosed and managed with antifungal medications. Most simple cases are resolved within days.&#x000a0;Patients with complicated candidal vulvovaginitis require more extended therapy. Pharmacists and pharmacy technicians can help direct patients toward appropriate therapy. Pregnant patients should not be given oral antifungals. In these patients, a 7-day course of intravaginal treatment is appropriate. Fluconazole is considered safe in breastfeeding women. There is inadequate evidence to recommend intravaginal or oral yogurt therapy, intravaginal garlic, or douching.<xref ref-type="bibr" rid="article-30939.r20">[20]</xref></p>
        <p>At the same time, patient education is essential. The condition is not life-threatening but can be associated with embarrassment and withdrawal from sexual activities. It is also vital to maintain a broad differential diagnosis. Trauma, abuse, foreign body, malignancy, immune diseases, inflammatory bowel disease, and sexually transmitted infections can all present with vaginal discomfort. If treatment failure occurs, clinicians should always perform a careful and complete physical exam, appropriate ancillary testing, and further testing.</p>
      </sec>
      <sec id="article-30939.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30939&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30939">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/vaginal-candidiasis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30939">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30939/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30939">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30939.s16">
        <title>References</title>
        <ref id="article-30939.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Achkar</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Fries</surname>
                <given-names>BC</given-names>
              </name>
            </person-group>
            <article-title>Candida infections of the genitourinary tract.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>253</fpage>
            <page-range>253-73</page-range>
            <pub-id pub-id-type="pmid">20375352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin Lopez</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Candidiasis (vulvovaginal).</article-title>
            <source>BMJ Clin Evid</source>
            <year>2015</year>
            <month>Mar</month>
            <day>16</day>
            <volume>2015</volume>
            <pub-id pub-id-type="pmid">25775428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farhan</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Moharram</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Salah</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shaaban</surname>
                <given-names>OM</given-names>
              </name>
            </person-group>
            <article-title>Types of yeasts that cause vulvovaginal candidiasis in chronic users of corticosteroids.</article-title>
            <source>Med Mycol</source>
            <year>2019</year>
            <month>Aug</month>
            <day>01</day>
            <volume>57</volume>
            <issue>6</issue>
            <fpage>681</fpage>
            <page-range>681-687</page-range>
            <pub-id pub-id-type="pmid">30544194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Denning</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Kneale</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sobel</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Rautemaa-Richardson</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Global burden of recurrent vulvovaginal candidiasis: a systematic review.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>11</issue>
            <fpage>e339</fpage>
            <page-range>e339-e347</page-range>
            <pub-id pub-id-type="pmid">30078662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Makanjuola</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bongomin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fayemiwo</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>An Update on the Roles of Non-<italic>albicans</italic><italic>Candida</italic> Species in Vulvovaginitis.</article-title>
            <source>J Fungi (Basel)</source>
            <year>2018</year>
            <month>Oct</month>
            <day>31</day>
            <volume>4</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">30384449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sobel</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Recurrent vulvovaginal candidiasis.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>214</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-21</page-range>
            <pub-id pub-id-type="pmid">26164695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Meijden</surname>
                <given-names>WI</given-names>
              </name>
              <name>
                <surname>Boffa</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Ter Harmsel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kirtschig</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Moyal-Barracco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tiplica</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Sherrard</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>2021 European guideline for the management of vulval conditions.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>952</fpage>
            <page-range>952-972</page-range>
            <pub-id pub-id-type="pmid">35411963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yano</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sobel</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Nyirjesy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sobel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Noverr</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Fidel</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes.</article-title>
            <source>BMC Womens Health</source>
            <year>2019</year>
            <month>Mar</month>
            <day>29</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <pub-id pub-id-type="pmid">30925872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Schalkwyk</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yudin</surname>
                <given-names>MH</given-names>
              </name>
              <collab>INFECTIOUS DISEASE COMMITTEE</collab>
            </person-group>
            <article-title>Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.</article-title>
            <source>J Obstet Gynaecol Can</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>266</fpage>
            <page-range>266-274</page-range>
            <pub-id pub-id-type="pmid">26001874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buggio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Somigliana</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Borghi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vercellini</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Probiotics and vaginal microecology: fact or fancy?</article-title>
            <source>BMC Womens Health</source>
            <year>2019</year>
            <month>Jan</month>
            <day>31</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <pub-id pub-id-type="pmid">30704451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnes</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vieira</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Harwood</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chauhan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Self-taken vaginal swabs versus clinician-taken for detection of candida and bacterial vaginosis: a case-control study in primary care.</article-title>
            <source>Br J Gen Pract</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>67</volume>
            <issue>665</issue>
            <fpage>e824</fpage>
            <page-range>e824-e829</page-range>
            <pub-id pub-id-type="pmid">29158246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Donders</surname>
                <given-names>GGG</given-names>
              </name>
              <name>
                <surname>Ravel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vitali</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Netea</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Salumets</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Unemo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Role of Molecular Biology in Diagnosis and Characterization of Vulvo-Vaginitis in Clinical Practice.</article-title>
            <source>Gynecol Obstet Invest</source>
            <year>2017</year>
            <volume>82</volume>
            <issue>6</issue>
            <fpage>607</fpage>
            <page-range>607-616</page-range>
            <pub-id pub-id-type="pmid">29017160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Workowski</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bachmann</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Muzny</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Reno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zenilman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bolan</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Sexually Transmitted Infections Treatment Guidelines, 2021.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2021</year>
            <month>Jul</month>
            <day>23</day>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>1</fpage>
            <page-range>1-187</page-range>
            <pub-id pub-id-type="pmid">34292926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aguirre-Qui&#x000f1;onero</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Castillo-Sedano</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Calvo-Muro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Canut-Blasco</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of the BD MAX&#x02122; vaginal panel in the diagnosis of infectious vaginitis.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2019</year>
            <month>May</month>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>877</fpage>
            <page-range>877-882</page-range>
            <pub-id pub-id-type="pmid">30685805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sobel</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Sobel</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.</article-title>
            <source>Expert Opin Pharmacother</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>19</volume>
            <issue>9</issue>
            <fpage>971</fpage>
            <page-range>971-977</page-range>
            <pub-id pub-id-type="pmid">29932786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Meijden</surname>
                <given-names>WI</given-names>
              </name>
              <name>
                <surname>Boffa</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Ter Harmsel</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Kirtschig</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Moyal-Barracco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tiplica</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Sherrard</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>2016 European guideline for the management of vulval conditions.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>925</fpage>
            <page-range>925-941</page-range>
            <pub-id pub-id-type="pmid">28164373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blostein</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Levin-Sparenberg</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Foxman</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Recurrent vulvovaginal candidiasis.</article-title>
            <source>Ann Epidemiol</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>27</volume>
            <issue>9</issue>
            <fpage>575</fpage>
            <page-range>575-582.e3</page-range>
            <pub-id pub-id-type="pmid">28927765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paavonen</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Brunham</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin Number 215.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>May</month>
            <volume>135</volume>
            <issue>5</issue>
            <fpage>1229</fpage>
            <page-range>1229-1230</page-range>
            <pub-id pub-id-type="pmid">32332401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooke</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Deckx</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pirotta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van Driel</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Treatment for recurrent vulvovaginal candidiasis (thrush).</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2022</year>
            <month>Jan</month>
            <day>10</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>CD009151</fpage>
            <pub-id pub-id-type="pmid">35005777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30939.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crouss</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sobel</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nyirjesy</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Long-Term Outcomes of Women With Recurrent Vulvovaginal Candidiasis After a Course of Maintenance Antifungal Therapy.</article-title>
            <source>J Low Genit Tract Dis</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>382</fpage>
            <page-range>382-386</page-range>
            <pub-id pub-id-type="pmid">29975334</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
